slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 21,811-21,840
Pages 1,371
Rows per page 30
Component
21,811-21,840 of 41,127
01
Aeglea BioTherapeutics | Investor Presentation Deck | 22 slidesAeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Attention1 hit
02
Aeglea BioTherapeutics | Investor Presentation Deck | 22 slidesAeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Attention1 hit
10
The slide uses a heatmap-style visualization to track individual patient progress across three mobility metrics (6MWT, GMFM-D, GMFM-E).Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
22
Aeglea BioTherapeutics | Investor Presentation Deck | 22 slidesAeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
01
arm | Investor Presentation Deck | 18 slidesarm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
02
Includes date reference: June 13, 2022.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
03
The slide uses a numbered list to present five key pillars of the company's value proposition.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
06
The slide uses a Gantt-style visualization to show drug development progress.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
12
Includes a dual-chart visualization comparing MADRS scores and CADSS scores from a third-party study.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
21
The slide highlights positive cognitive signals from a Phase 2 study, specifically emphasizing the efficacy of lower doses of RL-007.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
30
Includes a line chart showing HCQN subscale scores over time and a process diagram for the ongoing trial.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
41
The table compares four different compounds (COMP360, VLS-01, RLS-01, PCN-101) across various clinical and commercial dimensions.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
02
Azek | IPO Presentation Deck | 43 slidesAzek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Setup1 hit
22
Includes two sets of bar charts for brand ratings and two donut charts for market share.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · DesireLoop · Mece Breakdown1 hit
12
Includes Kaplan-Meier survival curve and geographic incidence data.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
14
Clinical trial data presentation for Legend Biotech's LEGEND-2 study.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
15
The slide uses a process flow diagram to illustrate the patient journey through the clinical trial.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
17
Data from CARTITUDE-1 Phase 1b study presented at ASCO 2020.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
18
Swimmer plot visualization of clinical trial patient outcomes.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
19
Clinical trial summary slide for Legend Biotech.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
20
Uses a process-flow diagram to map clinical trial progression.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
02
Maersk | Investor Presentation Deck | 53 slidesMaersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Attention1 hit
34
The slide compares nominal capacity growth with effective capacity and demand growth, highlighting a contraction in Q1 2020.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
41
The slide provides a detailed breakdown of unit costs for Maersk in 2019, supported by a donut chart and a detailed footnote explaining the composition of each cost category.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
42
The chart tracks TEU capacity alongside a breakdown of owned vs chartered vessels.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
02
Overstock | Shareholder Engagement Presentation Deck | 20 slidesOverstock | Shareholder Engagement Presentation Deck | 20 slides · Overstock
Conference presentation Investor relations Beat · Attention1 hit
13
The chart uses a bar chart to show year-over-year growth in GMV across four distinct time periods, with a callout for the March 13th event.Overstock | Shareholder Engagement Presentation Deck | 20 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
16
The slide highlights the virtuous cycle between buyers and consignors, supported by strong repeat customer metrics.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations Beat · DesireLoop · Pattern Hunter1 hit
21
The slide uses a combination of donut charts for total sell-through and stacked bar charts for inventory aging.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations Beat · Desire1 hit
32
The slide provides a detailed breakdown of unit economics, specifically highlighting the improvement in contribution margin.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations Beat · Action1 hit